- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/04 - BenzimidazolesHydrogenated benzimidazoles
Patent holdings for IPC class C07D 235/04
Total number of patents in this class: 309
10-year publication summary
|
11
|
21
|
14
|
22
|
26
|
17
|
13
|
12
|
11
|
12
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| UCB Biopharma SRL | 599 |
11 |
| Boehringer Ingelheim International GmbH | 4493 |
6 |
| Merck Sharp & Dohme Corp. | 2183 |
5 |
| Universal Display Corporation | 2085 |
5 |
| Daewoong Pharmaceutical Co., Ltd. | 363 |
4 |
| University of Maryland, Baltimore | 1068 |
4 |
| Vectus Biosystems Limited | 29 |
4 |
| Merck Sharp & Dohme LLC | 3734 |
4 |
| Centre National de La Recherche Scientifique | 11023 |
3 |
| Semiconductor Energy Laboratory Co., Ltd. | 11821 |
3 |
| Nitto Denko Corporation | 8536 |
3 |
| University of Florida Research Foundation, Inc. | 4174 |
3 |
| HT Materials Corporation | 14 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 852 |
3 |
| Toyama Chemical Co., Ltd. | 88 |
3 |
| vTv Therapeutics LLC | 152 |
3 |
| The Wistar Institute of Anatomy and Biology | 484 |
3 |
| Terns Pharmaceuticals, Inc. | 86 |
3 |
| Bristol-myers Squibb Company | 4742 |
2 |
| Janssen Pharmaceutica N.V. | 3168 |
2 |
| Other owners | 232 |